ArticleCureus2025
A Case of Non-ketotic Hyperglycemic Hemichorea-Hemiballismus in a 54-Year-Old Male Individual With Type 2 Diabetes Mellitus.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Non-ketotic hyperglycemic hemichorea-hemiballismus syndrome is a rare neurological condition associated with hyperglycemia from uncontrolled type 2 diabetes mellitus. The disease is diagnosed via clinical presentation, laboratory evaluation, and neuroimaging. With a prompt diagnosis, glycemic control is initiated as the mainstay of treatment. Additional management of chorea symptoms can be completed with neuroleptics. Here, we report a case of a 54-year-old male individual presenting with unilateral, involuntary, and uncontrollable muscle contractions secondary to non-ketotic hyperglycemia. He was managed with strict glycemic control only. Significant improvement in symptoms was noted two months after diagnosis. A complete recovery is expected within six months of onset.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.